About Rexcin Pharmaceuticals Private Limited
Data last updated:
Rexcin Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 December 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2003PTC123544. Its GSTIN is 07AACCR6446C1ZJ (Delhi). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹28 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Satinder Pal Singh and Pradeep Saxena.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 17 – B First Floor Block A – 1A Janakpuri, New Delhi, Delhi, India – 110058.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.57 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹2.05 Cr (net margin 23.8%) and EBITDA of ₹2.81 Cr (EBITDA margin 32.8%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 8% over five years.
The company has about 1 employee on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Rexcin Pharmaceuticals. Court records list 60 cases involving the company, including 55 filed by the company and 5 filed against it; 23 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rexcinpharma.com.
Company details
Contact details
Rexcin Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is rexcinpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressFlat No. 17 – B First Floor Block A – 1A Janakpuri, New Delhi, Delhi, India – 110058
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Rexcin Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Rexcin Pharmaceuticals operates one associated brand: Rexcin Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and markets dermatological pharmaceutical products. | rexcinpharma.com |
Business activity
The main business activities of Rexcin Pharmaceuticals are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rexcin Pharmaceuticals Private Limited, buy the company report.
Financials of Rexcin Pharmaceuticals Private Limited
FY 2025 filings availableRexcin Pharmaceuticals Private Limited reported revenue of ₹8.57 Cr (up 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 15% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 8%. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.81 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.05 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 32.8% | ||||
| Net Profit Margin | 23.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rexcin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rexcin Pharmaceuticals Private Limited
Rexcin Pharmaceuticals has 2 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satinder Pal Singh | Director | 15 Jul 2015 | 11 Years 3 Months | Current |
| Pradeep Saxena | Director | 31 Jul 2013 | 13 Years 3 Months | Current |
Peer comparison
Rexcin Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rebase Lifescience Private Limited | ₹8.59 Cr (FY 2025) | 8.0% | Lalpur, Gujarat, India | |||
| Qpharm Health Care Limited | ₹8.59 Cr (FY 2024) | 40.0% | Jaipur, Rajasthan, India | |||
| Rexcin Pharmaceuticals Private Limitedthis company | ₹8.57 Cr (FY 2025) | ₹2.05 Cr | 23.8% | 15.0% | 1 | New Delhi, Delhi, India |
| Lutim Pharma Private Limited | ₹8.57 Cr (FY 2024) | 6.0% | Dehradun, Uttarakhand, India | |||
| Heal (India) Laboratories Private Limited | ₹8.57 Cr (FY 2025) | 52.0% | Thiruvellor, Tamil Nadu, India | |||
| Medrhans Pharmaceuticals Private Limited | ₹8.54 Cr (FY 2025) | 107.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Rexcin Pharmaceuticals Private Limited, buy the company report.
Auditor
Rexcin Pharmaceuticals Private Limited is audited by M S SEKHON & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M S SEKHON & CO | FY 2019 | 003671N |
Shareholding
The shareholding of Rexcin Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Rexcin Pharmaceuticals Private Limited, buy the company report.
Legal cases
Rexcin Pharmaceuticals Private Limited has 60 court cases on record: 55 filed by Rexcin Pharmaceuticals, 5 filed against it. 23 cases are pending and 37 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 57 | 2 | 23 |
| Supreme Court | 2 | 2 | 0 |
| District courts | 1 | 1 | 0 |
Cases on record (5 of 60)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Rekin Pharma Private Limited | Disposed |
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed by the company against Rekin Pharma P Ltd & Anr. | Disposed |
| High Court of Delhi | Commercial suit | Filed by the company against Rekin Pharma Pvt Ltd | Disposed |
| District court, South West, Delhi | Court case (CS DJ ADJ) | Filed against the company by Rekin Pharma Pvt Ltd Through Its Director and 1 other | Disposed |
| High Court, TAMIL NADU | Interim or miscellaneous application | Filed against the company by The Registrar of Trademarks M/S.Prasad Vijayakumar, ------------------------------,M/S.A.R.Sakthivel, Sr. Panel Counsel for Petitioner ( Memo of Appearance Filed) | Pending |
To see the full case history of Rexcin Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rexcin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Rexcin Pharmaceuticals has 1 subsidiary company and 2 associated companies. This group structure data is as of FY 2019. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Best Laboratories Private Limited | U74999DL2003PTC123593 |
To see the full group structure of Rexcin Pharmaceuticals Private Limited, buy the company report.
Employees & EPFO
Rexcin Pharmaceuticals Private Limited has a workforce of 1 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Rexcin Pharmaceuticals has 4 GST registrations: 3 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCR6446C1ZJ | Delhi | Active | 01 Jul 2017 |
| 02AACCR6446C1ZT | Himachal Pradesh | Active | 01 Jul 2017 |
| 23AACCR6446C1ZP | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rexcin Pharmaceuticals Private Limited, buy the company report.
Recent activity
Rexcin Pharmaceuticals Private Limited has 17 board changes on record since 2007: 2 appointments and 15 cessations. The latest: Digvijay Singh Chauhan ceased to be Additional Director on 02 Dec 2015.
8 earlier events are in the company report.
Frequently asked questions
Rexcin Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 December 2003 (23+ years old) and is registered under CIN U24239DL2003PTC123544.
Rexcin Pharmaceuticals has 2 current directors:
- Satinder Pal Singh - Director
- Pradeep Saxena - Director
The latest financial statements of Rexcin Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Rexcin Pharmaceuticals is 07AACCR6446C1ZJ, registered in Delhi. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 02AACCR6446C1ZT (Himachal Pradesh), 23AACCR6446C1ZP (Madhya Pradesh).
The CIN (Corporate Identification Number) of Rexcin Pharmaceuticals is U24239DL2003PTC123544. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rexcin Pharmaceuticals has 60 court cases on record: 55 filed by the company and 5 filed against it. 23 are pending. Most are in the high courts.
Rexcin Pharmaceuticals was incorporated on 16 December 2003, making it 23+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Rexcin Pharmaceuticals by revenue are Rebase Lifescience Private Limited, Qpharm Health Care Limited, Lutim Pharma Private Limited, Heal (India) Laboratories Private Limited, Medrhans Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Digvijay Singh Chauhan ceased to be Additional Director on 02 Dec 2015. Satinder Pal Singh ceased to be Additional Director on 30 Sep 2015. Satinder Pal Singh was appointed as Director on 15 Jul 2015. Rexcin Pharmaceuticals has 17 board changes on record in total.
Rexcin Pharmaceuticals can be reached through the website rexcinpharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Rexcin Pharmaceuticals is at Flat No. 17 – B First Floor Block A – 1A Janakpuri, New Delhi, Delhi, India – 110058.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
